Related by context. Frequent words. (Click for all words.) 81 Phase 2a trial 80 Phase 2b study 80 Phase IIa 80 Phase 2a clinical 79 Phase IIa clinical 79 Phase 2b trial 78 Phase 2a 78 Phase IIb trial 78 Phase Ib 77 Phase IIb 77 Phase IIb clinical 76 phase IIb 75 Phase 2b clinical 75 Phase III clinical 74 Phase III trials 74 Phase 1b 74 pivotal Phase III 74 Phase III clinical trials 74 Phase 2b 73 Phase III 71 dose escalation trial 71 Phase III pivotal 70 clinical trial 70 PRX # 69 dose escalation study 69 multiple ascending dose 69 confirmatory Phase 3 68 NGX# 67 pivotal Phase 67 clinical trials 67 Phase II 67 investigational compound 66 randomized Phase 65 single ascending dose 65 preclinical studies 65 pharmacokinetic 65 ADX# 64 HGS ETR1 64 INCB# [002] 64 CRx 64 placebo controlled 64 preclinical 63 IND enabling 63 randomized placebo controlled 63 Marqibo 63 ISIS # 63 tolerability 63 HspE7 63 IMGN# 63 investigational drug 63 RDEA# 63 MGCD# [001] 63 CYT# 63 dose escalation 63 eculizumab 62 ZYBRESTAT 62 label dose escalation 62 double blind placebo 62 AZD# 62 RG# [001] 62 blinatumomab 62 ofatumumab 62 mipomersen 62 Bronchitol 62 investigational 62 safety tolerability 61 cetrorelix 61 pharmacodynamics 61 midstage study 61 LymphoStat B 61 MLN# 61 denufosol 61 IDX# 61 investigational oral 61 Iluvien 61 Atiprimod 61 AEZS 61 Perifosine 61 ALKS 61 Marketing Authorization Application 61 daclizumab 61 oral formulation 61 Marketing Authorization Application MAA 61 Biologics License Application BLA 60 blind randomized placebo 60 Zerenex 60 relapsing remitting multiple sclerosis 60 microplasmin 60 vilazodone 60 DSMB 60 Torisel 60 Locteron 60 tolerability profile 60 multicenter 60 ALTU 60 multicenter randomized double 60 pharmacokinetic profile 60 pharmacodynamic 60 Cimzia ® 60 cutaneous T cell 60 laquinimod